JP2011528355A - 充血除去剤およびコルチコステロイドを含む鼻腔内粗製物 - Google Patents

充血除去剤およびコルチコステロイドを含む鼻腔内粗製物 Download PDF

Info

Publication number
JP2011528355A
JP2011528355A JP2011518814A JP2011518814A JP2011528355A JP 2011528355 A JP2011528355 A JP 2011528355A JP 2011518814 A JP2011518814 A JP 2011518814A JP 2011518814 A JP2011518814 A JP 2011518814A JP 2011528355 A JP2011528355 A JP 2011528355A
Authority
JP
Japan
Prior art keywords
oxymetazoline
symptoms
dosage form
pharmaceutically acceptable
allergic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2011518814A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011528355A5 (enExample
Inventor
メルビン アール． ダンジグ，
アリエル テパー，
デイビス エフ． ゲイツ，
ヘリバート ダブリュー． スタウディンガー，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of JP2011528355A publication Critical patent/JP2011528355A/ja
Publication of JP2011528355A5 publication Critical patent/JP2011528355A5/ja
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2011518814A 2008-07-15 2009-07-13 充血除去剤およびコルチコステロイドを含む鼻腔内粗製物 Withdrawn JP2011528355A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US8099008P 2008-07-15 2008-07-15
US61/080,990 2008-07-15
US11672108P 2008-11-21 2008-11-21
US61/116,721 2008-11-21
PCT/US2009/050361 WO2010009028A1 (en) 2008-07-15 2009-07-13 Intranasal compositions comprising a decongestant and a corticosteroid

Publications (2)

Publication Number Publication Date
JP2011528355A true JP2011528355A (ja) 2011-11-17
JP2011528355A5 JP2011528355A5 (enExample) 2012-08-30

Family

ID=41259574

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011518814A Withdrawn JP2011528355A (ja) 2008-07-15 2009-07-13 充血除去剤およびコルチコステロイドを含む鼻腔内粗製物

Country Status (13)

Country Link
US (1) US20110189106A1 (enExample)
EP (1) EP2318049A1 (enExample)
JP (1) JP2011528355A (enExample)
KR (1) KR20110045004A (enExample)
CN (1) CN102159244A (enExample)
AR (1) AR072805A1 (enExample)
AU (1) AU2009271162A1 (enExample)
CA (1) CA2730590A1 (enExample)
CO (1) CO6331447A2 (enExample)
MX (1) MX2011000590A (enExample)
RU (1) RU2011101151A (enExample)
TW (1) TW201016209A (enExample)
WO (1) WO2010009028A1 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016531949A (ja) * 2013-10-04 2016-10-13 グレンマーク・スペシャルティー・エスエー モメタゾンおよびオロパタジンの組み合わせを使用するアレルギー性鼻炎の治療
JP2020073510A (ja) * 2014-03-26 2020-05-14 オプティノーズ アズ 経鼻投与
US11554229B2 (en) 2013-03-26 2023-01-17 OptiNose Inc. Nasal administration

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012505236A (ja) * 2008-10-10 2012-03-01 シェーリング コーポレイション コルチコステロイド組成物およびそれの治療方法
AU2012291841A1 (en) * 2011-08-02 2014-02-06 Cipla Limited Pharmaceutical composition comprising ebastine and fluticasone
US9757529B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
US9757395B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
JP2016518388A (ja) 2013-04-30 2016-06-23 オティトピック インク． 乾燥粉末配合および使用方法
US10758550B2 (en) 2013-10-04 2020-09-01 Glenmark Specialty S.A. Treatment of allergic rhinitis using a combination of mometasone and olopatadine
US10016443B2 (en) 2013-10-04 2018-07-10 Glenmark Specialty S.A. Treatment of allergic rhinitis using a combination of mometasone and olopatadine
US10548907B2 (en) 2013-10-04 2020-02-04 Glenmark Specialty S.A. Treatment of allergic rhinitis using a combination of mometasone and olopatadine
US10653661B2 (en) 2013-10-04 2020-05-19 Glenmark Specialty S.A. Treatment of allergic rhinitis using a combination of mometasone and olopatadine
US11679210B2 (en) 2014-10-03 2023-06-20 Glenmark Specialty S.A. Dispensing device and pharmaceutical composition for the treatment of rhinitis
CN106692115A (zh) * 2015-11-13 2017-05-24 天津金耀集团有限公司 一种环索奈德混悬鼻喷剂组合物
KR102507987B1 (ko) 2017-09-22 2023-03-21 벡추라 인코포레이티드 스테아르산마그네슘을 갖는 건조 분말 조성물
US10786456B2 (en) 2017-09-22 2020-09-29 Otitopic Inc. Inhaled aspirin and magnesium to treat inflammation
US12303635B2 (en) 2018-04-16 2025-05-20 Glenmark Specialty S.A. Dispensing device and pharmaceutical composition for the treatment of rhinitis
CN112006987B (zh) * 2019-12-13 2023-04-28 吉林省健敷鼻科技有限公司 一种治疗鼻炎的冷敷凝胶及其之制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040053902A1 (en) * 2002-09-13 2004-03-18 Smith C. Steven Novel composition and method for treatment of upper respiratory conditions
US20040191176A1 (en) * 2003-03-28 2004-09-30 Kaplan Leonard W Formulations for treatment of pulmonary disorders
US20040235807A1 (en) * 2003-05-21 2004-11-25 Weinrich Karl P. Formulations including a topical decongestant and a topical corticosteroid suitable for nasal administration and method for treating obstructive sleep apnea
US7902177B2 (en) * 2005-05-02 2011-03-08 Wandzel Richard A Treatment of congestion using steroids and adrenergics
WO2008070264A2 (en) * 2006-10-10 2008-06-12 Case Western Reserve University Nasal spray composition and method for treating rhinitis, sinusitis or both

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11554229B2 (en) 2013-03-26 2023-01-17 OptiNose Inc. Nasal administration
JP2016531949A (ja) * 2013-10-04 2016-10-13 グレンマーク・スペシャルティー・エスエー モメタゾンおよびオロパタジンの組み合わせを使用するアレルギー性鼻炎の治療
JP2018123157A (ja) * 2013-10-04 2018-08-09 グレンマーク・スペシャルティー・エスエー モメタゾンおよびオロパタジンの組み合わせを使用するアレルギー性鼻炎の治療
JP2020073510A (ja) * 2014-03-26 2020-05-14 オプティノーズ アズ 経鼻投与

Also Published As

Publication number Publication date
US20110189106A1 (en) 2011-08-04
WO2010009028A1 (en) 2010-01-21
AR072805A1 (es) 2010-09-22
TW201016209A (en) 2010-05-01
AU2009271162A1 (en) 2010-01-21
EP2318049A1 (en) 2011-05-11
CA2730590A1 (en) 2010-01-21
MX2011000590A (es) 2011-03-01
CN102159244A (zh) 2011-08-17
KR20110045004A (ko) 2011-05-03
CO6331447A2 (es) 2011-10-20
RU2011101151A (ru) 2012-07-20

Similar Documents

Publication Publication Date Title
JP2011528355A (ja) 充血除去剤およびコルチコステロイドを含む鼻腔内粗製物
US20090221541A1 (en) Pharmaceutical formulations
US20090238771A1 (en) Pharmaceutical formulations
JP2000508675A (ja) 新規製剤
IL216932A (en) Composition of pharmaceuticals containing azalastine and cyclozonide and method for the manufacture of a periodic allergy treatment containing this composition
US20100144610A1 (en) Pharmaceutical formulations
JP2014501779A (ja) ベポタスチン組成物
US20060030550A1 (en) Pharmaceutical formulations
JP2008110991A (ja) 処置方法
AU2012265231B2 (en) Nasal pharmaceutical formulation
NZ616149B2 (en) Nasal Pharmaceutical Formulation Comprising Fluticasone

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120712

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20120712

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20120718